OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2
The review is devoted to the modern data about mechanisms of cardiovascular dysfunction in patients suffering diabetes mellitus type 2, especially to the role of oxidative stress. It is determined that oxidative stress is involved in the development of myocardial ischemia, reperfusion-syndrome, endo...
Saved in:
| Main Authors: | K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/412 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxidative stress and endothelial dysfunction correction with ACE inhibitor therapy in patients with myocardial infarction and Type 2 diabetes mellitus
by: V. S. Zadionchenko, et al.
Published: (2008-10-01) -
ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01) -
Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01) -
POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
by: M. G. Bubnova
Published: (2013-02-01) -
Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01)